Speaker Profile
M.D., MPH, CMO, Lycia
Biography
Chin Lee leads clinical development of Lycia Therapeutics’ lysosomal targeting chimeras (LYTACs), novel protein degraders designed to clear extracellular disease-causing proteins, for the treatment of autoimmune and allergic diseases. He joined Lycia from Allakos, where he oversaw development of therapeutics for allergic and inflammatory diseases. He previously held leadership positions at Connect Biopharma, Theravance Biopharma, Genentech, Eli Lilly, and Abbott (now AbbVie). Across these roles he has guided therapies from early- through late-phase development and regulatory approval in multiple immunology and inflammation indications. Earlier in his career, Dr. Lee was a faculty member in the Division of Rheumatology at the Northwestern University Feinberg School of Medicine. He earned an M.D. from the University of North Carolina at Chapel Hill, and an M.P.H. from Northwestern University.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Mark Genovese, Eli Lilly
PMWC Award Ceremony
• Miriam Merad, Mount Sinai (Luminary)
• Jeffrey A. Bluestone, UCSF (Luminary)
Featured Speakers
• Miriam Merad, Mount Sinai
• Jeffrey A. Bluestone, UCSF
• Gallia Levy, Gilead
• Marcela V. Maus, Harvard
• Nick Wilson, Biogen
• Megan Levings, BC Children's Hospital Research Institute
• Min Bao, Kali Therapeutics
• Purvesh Khatri, Stanford
• Heleen Scheerens, Genentech
• Pascal Geldsetzer, Stanford
• Dan Littman, NYU
• Anne Kasmar, Parexel
Macrophages Across Inflammation, Cancer & Aging
Master regulators of tissue health and disease across precision immunology.
Immune Reset in Autoimmune Disease
CAR-T, in vivo CAR, and the pursuit of durable remission.
Beyond Broad Immunosuppression
Tolerance, Tregs, and disease-modifying approaches.
Turning Biomarkers on Their Head
What we can measure before we can reliably predict response.
Precision Immunology in Clinical Development
Trial enrichment, deeper endpoints, response prediction, and regulatory strategy.
The Microbial Roots of Autoimmunity
Chronic infection, dysbiosis, and microbial signals shaping disease.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
